Can drug price hikes via debranding be prevented?

Tools

Bokhari, Farasat ORCID: https://orcid.org/0000-0001-5418-8078 and Lyons, Bruce (2017) Can drug price hikes via debranding be prevented? Prescriber, 28 (4). pp. 44-46.

[thumbnail of Accepted manuscript]
Preview
 PDF (Accepted manuscript) - Accepted Version
Download (175kB) | Preview

Abstract

Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

Item Type: Article
Faculty \ School: Faculty of Social Sciences > School of Economics
UEA Research Groups: Faculty of Social Sciences > Research Groups > Industrial Economics
Faculty of Social Sciences > Research Centres > Centre for Competition Policy
Related URLs:
Depositing User: Pure Connector
Date Deposited: 12 May 2017 05:05
Last Modified: 18 Jun 2026 17:29
URI: https://ueaeprints.uea.ac.uk/id/eprint/63483
DOI: 10.1002/psb.1563

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item